American College of Cardiology

SEPTEMBER 2, 2024

The goal of the INFINITY-SWEDEHEART trial was to compare the efficacy of the DynamX bioadaptor, a novel coronary implantable device, to a contemporary drug-eluting stent (DES) in the treatment of coronary artery disease requiring percutaneous coronary intervention (PCI).

Stent 50

Stent Stents Coronary Artery Disease Article 50

American College of Cardiology

OCTOBER 28, 2024

The goal of the DCB-BIF trial was to assess the efficacy of drug-coated balloon (DCB) angioplasty of residual side branch stenosis in coronary bifurcation lesions treated with a provisional stenting strategy.

Angioplasty 56

Angioplasty Stent Stents Stenosis 56

American College of Cardiology

NOVEMBER 26, 2024

Use of intravascular lithotripsy (IVL) for the treatment of in-stent restenosis (ISR), although off-label, may be safe and feasible, according to a study reviewing data from the ACC's CathPCI Registry published in JACC: Cardiovascular Interventions.

Stent 50

Stent Stents Cardiovascular Interventions Article 50

Cardiology Update

MARCH 25, 2024

Original article: Gaba P et al. Pooled data from four trials were analyzed, encompassing patients undergoing PCI or CABG for left main disease. These findings underscore the importance of individualized treatment approaches in left main disease management. Circulation. 2024;149:00–00.

Diabetes 122

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease 122

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

This study aimed to explore the relationship between in-stent neoatherosclerosis (ISNA) and the neutrophil-to-lymphocyte ratio (NLR) in patients with in-stent restenosis (ISR) following drug-eluting stent (DES) implantation. We divided 216 patients into three groups based on the NLR tertile. Copyright © 2024 The Author(s).

Stent 40

Stent Stents Plaque Article 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty).

Angioplasty 40

Angioplasty Stent Stents Stenosis 40

American College of Cardiology

SEPTEMBER 2, 2024

A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)

Angioplasty 40

Angioplasty Stent Stents Article 40

Stroke Journal

FEBRUARY 1, 2024

Background:Advancements in arterial stenting technology have challenged prior notions favoring medical management over endovascular intervention for intracranial atherosclerotic disease (ICAD). Stroke, Volume 55, Issue Suppl_1 , Page ATP202-ATP202, February 1, 2024.

Stent 40

Stent Stents Technology Article 40

Dr. Smith's ECG Blog

JANUARY 31, 2020

Angiogram: Widely patent RCA and LAD stents. Therefore, no stent was placed. (No It is proven better than angiography alone in stable angina , and also has been shown to improve decisions on stenting non-culprit lesions in ACS. We are told that this middle-aged male patient has a history of prior MI with stents.

Angina 52

Angina Stent Stents Aneurysm 52

American College of Cardiology

MARCH 20, 2024

The goal of the AGENT IDE trial was to assess the safety and efficacy of a paclitaxel-coated balloon (drug-coated balloon; DCB) to conventional balloon angioplasty among patients with coronary in-stent restenosis (ISR).

Stent 45

Stent Stents Angioplasty Article 45

American College of Cardiology

JANUARY 4, 2024

The goal of the STOPDAPT-2 trial was to evaluate 1-month dual antiplatelet therapy (DAPT) compared with 12-month DAPT among patients undergoing percutaneous coronary intervention (PCI).

Stent 75

Stent Stents Article 75

Journal of Cardiovascular Pharmacology

NOVEMBER 26, 2023

Abstract: The mechanism of in-stent restenosis (ISR) remains elusive, and in-stent neoatherosclerosis (ISNA) may hold siginificant pathophysiological implications. The mechanism of in-stent restenosis (ISR) remains elusive, and in-stent neoatherosclerosis (ISNA) may hold siginificant pathophysiological implications.

Atherosclerosis 40

Atherosclerosis Stent Stents Plaque 40

Cardiology Update

FEBRUARY 26, 2024

Independent predictors of aortic valve complex and perivalvular thrombus included a small maximum stent diameter at the valve level and a low body surface area. Original article: Choi Y et al. Specifically, 14.2% of patients exhibited leaflet thrombus, while 37.0% had perivalvular thrombus. J Am Coll Cardiol Intv 2023;16:2967–2981.

TAVR 122

TAVR Aortic valve Outcomes Aortic 122

American College of Cardiology

JANUARY 5, 2024

The first carotid stent system achieved approval by the U.S. Food and Drug Administration (FDA) for high-surgical risk patients in 2004.

Stent 40

Stent Stents Article 40

The British Journal of Cardiology

NOVEMBER 10, 2023

The near-immediate or instant feedback learning process by which the heart responds to any new invasive procedural variation facilitates each new change; be it drug-eluting stent, drug-coated balloon, or both in different combinations and permutations.

Stent 40

Stent Stents Coronary Artery Disease Myocardial Infarction 40

American College of Cardiology

DECEMBER 2, 2024

Is there a benefit to perioperative continuation of aspirin in patients with coronary drug-eluting stents (DES) undergoing noncardiac surgery?

Stent 72

Stent Stents Article 72

American College of Cardiology

DECEMBER 20, 2024

The goal of the HOST-EXAM trial was to assess the safety and efficacy of clopidogrel vs. aspirin monotherapy among patients who had completed the required duration of dual antiplatelet therapy (DAPT) therapy postdrug-eluting stent (DES) percutaneous coronary intervention (PCI).

Stent 74

Stent Stents Article 74

Journal of Cardiovascular Electrophysiology

FEBRUARY 8, 2024

We present our experience performing concurrent lead extraction and dilation/stenting of venous pathways, including patients with complete venous obstruction. Three patients had complete obstructions, three required stenting of their innominate veins and three required recanalization of their femoral vessels. years (range 3.6−35.3

Congenital Heart Disease 40

Congenital Heart Disease Stent Stents Congenital 40

American College of Cardiology

OCTOBER 16, 2024

In this week’s View, Dr. Eagle looks at an individual patient data meta-analysis of semaglutide and blood pressure (BP). He then explores an analysis from COMBINE-AF on heart failure (HF) risk assessment using biomarkers in patients with atrial fibrillation.

Biomarkers 58

Biomarkers Blood Pressure Atrial Fibrillation Stent 58

American College of Cardiology

DECEMBER 22, 2023

The goal of the STOPDAPT-3 trial was to compare the safety and efficacy of an aspirin-free strategy among patients undergoing percutaneous coronary intervention (PCI) or at high bleeding risk.

Stent 61

Stent Stents Article 61

Dr. Smith's ECG Blog

JANUARY 27, 2024

Old ‘NSTEMI’ A history of coronary artery disease and a stent to the same territory further increases pre-test likelihood of acute coronary occlusion, including in-stent thrombosis. The patient had a history of ‘NSTEMI’ a decade prior, with an RCA stent. Does this change your interpretation?

Chest Pain 117

Chest Pain STEMI Aneurysm Stent 117

American College of Cardiology

MARCH 29, 2025

The goal of the HOST-BR trial was to determine the optimal duration of dual antiplatelet therapy (DAPT) for patients who were stratified by high or low bleeding risk after receiving PCI with drug-eluting stent.

Stent 56

Stent Stents Article 56

American College of Cardiology

OCTOBER 29, 2024

The routine use of orbital atherectomy did not improve minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary lesions.

Angioplasty 53

Angioplasty Stent Stents Article 53

American College of Cardiology

DECEMBER 4, 2024

In this week’s View, Dr. Eagle looks at the use of waist-high compression tights in patients with postural orthostatic tachycardia syndrome (POTS).

POTS 56

POTS Stent Stents Tachycardia 56

Frontiers in Cardiovascular Medicine

MARCH 10, 2024

Methods We conducted a comprehensive search for articles on PubMed and Embase using search strategies which yielded 4,061 articles. After full-text screening, 66 articles were included for systematic review, and 62 articles were further selected for meta-analysis. Overall, 55 (83.3%) studies were at low risk of bias.

Myocardial Infarction 59

Myocardial Infarction Cardiogenic Shock Article STEMI 59

American College of Cardiology

JULY 15, 2024

The goal of the ILUMIEN IV: OPTIMAL PCI trial was to evaluate optical coherence tomography (OCT)-guided revascularization compared with angiography-guided revascularization among patients undergoing percutaneous coronary intervention (PCI).

Stent 50

Stent Stents Article 50

ADN Center of Excellence

NOVEMBER 7, 2024

In this article, we’ll explore some of the leading fellowship specialties, what they entail, and the career paths they open for doctors committed to continuous learning and professional growth. These fellowships are designed for those with a keen interest in mastering procedures that demand precision and expertise.

Cancer 59

Cancer Academic Research Interventional Cardiology 59

American College of Cardiology

SEPTEMBER 12, 2024

What is the evidence comparing dual antiplatelet therapy (DAPT) de-escalation to ticagrelor monotherapy versus continuing DAPT for 12 months after coronary drug-eluting stent implantation?

Stent 53

Stent Stents Article 53

American College of Cardiology

MARCH 20, 2024

He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis. Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI.

Coronary Artery Bypass Graft 60

Coronary Artery Bypass Graft Ultrasound Angioplasty Stent 60

American College of Cardiology

OCTOBER 29, 2024

The goal of the ECLIPSE trial was to evaluate orbital atherectomy prior to drug-eluting stent (DES) implantation compared with conventional percutaneous coronary intervention (PCI) without atherectomy among patients with calcified coronary lesions.

Angioplasty 53

Angioplasty Stent Stents Article 53

The British Journal of Cardiology

OCTOBER 8, 2024

That, it was possible to treat atherosclerotic coronary artery disease with an updated Andreas Grüntzig’s balloon alone, without the safety net and comfort of implanting a single stent. Three interactive cases were treated with the drug-coated balloon and all patients were same-day discharged.

Coronary Artery Disease 40

Coronary Artery Disease Stent Stents Hospital 40

American College of Cardiology

MARCH 8, 2024

The following are key points to remember from an updated network meta-analysis on intravascular imaging-guided coronary drug-eluting stent (DES) implantation.

Stent 56

Stent Stents Article 56

American College of Cardiology

AUGUST 31, 2024

Continuing aspirin monotherapy for patients with previous drug-eluting stents (DES) who are undergoing low-to-intermediate risk noncardiac surgery did not significantly reduce ischemic events compared with temporarily holding all antiplatelet therapy before the surgery, according to findings from the ASSURE DES trial presented at ESC Congress 2024 (..)

Stent 53

Stent Stents Article 53

American College of Cardiology

MARCH 18, 2024

What is the impact of systematic implementation of quantitative coronary angiography (QCA) to assist angiography-guided percutaneous coronary intervention (PCI) as an alternative strategy to intravascular ultrasonography (IVUS) guidance during stent implantation?

Stent 53

Stent Stents Article 53

American College of Cardiology

OCTOBER 30, 2024

A biodegradable polymer sirolimus-eluting stent (BP-SES) was noninferior to currently-used second-generation drug-eluting stents (DES) in terms of target lesion failure (TLF) at one year in patients undergoing PCI for chronic or acute coronary syndromes, based on findings from the TARGET-IV NA trial.

Stent 40

Stent Stents Article 40

EMS 12-Lead

AUGUST 18, 2024

Ultimately the patient went to Cath and was found to have multi-vessel obstructive coronary disease with an acute LCX culprit vessel, which was stented. link] [link] Here’s a recent article from the JACC that not only summarizes previous WCT ECG research (eg, Brugada, Vereckei, etc), but presents a novel algorithm that may perform better.

Tachycardia 59

Tachycardia Blog RN Echocardiogram 59

American College of Cardiology

SEPTEMBER 2, 2024

Optical coherence tomography (OCT) guidance during PCI resulted in a lower incidence of major adverse cardiac events at one year in patients requiring drug-eluting stent (DES) implantation for complex lesions, compared with angiography guidance, based on findings from the OCCUPI trial.

Stent 45

Stent Stents Article 45